CATB - Astria Therapeutics Inc
Previous close
8.4
0 0%
Share volume: 0
Last Updated: Thu 09 Sep 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$8.40
0.00
0.00%
Summary score
45%
Profitability
50%
Dept financing
3%
Liquidity
45%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.75%
Return on assets
-19.69%
Return on sales
0%
Return on invested capital
165.67%
Total debt ratio
18.97%
Debt ratio change over timeo
-0.85%
Current Ratio
7.34%
Quick Ratio
0%
Cash Position Ratio
3.55%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-17.26%
Return on assets
-15.43%
Return on sales
0%
Return on invested capital
248.31%
Total debt ratio
11.83%
Debt ratio change over timeo
-0.94%
Current Ratio
9.49%
Quick Ratio
0%
Cash Position Ratio
4.39%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.69%
Return on assets
-16.73%
Return on sales
0%
Return on invested capital
236.52%
Total debt ratio
10.91%
Debt ratio change over time
-0.96%
Current Ratio
10.09%
Quick Ratio
0%
Cash Position Ratio
9.46%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-120.95%
Return on assets
-115.49%
Return on sales
0%
Return on invested capital
7.89%
Total debt ratio
-84.53%
Debt ratio change over time
-0.85%
Current Ratio
3.65%
Quick Ratio
0%
Cash Position Ratio
1.43%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CATB | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -25.75% | 0% | 0% | 29.06% |
| Return on assets | -19.69% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 165.67% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 32% |
| Total debt ratio | 18.97% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.85% | 0% | 0% | 19.02% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 9.49% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.39% | 0% | 0% | 5.68% |
| Liquididy | 48% | 0% | 0% | 63% |
| Short-term ratios | CATB | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -17.26% | 0% | 0% | -16.12% |
| Return on assets | -15.43% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 248.31% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 10% |
| Total debt ratio | 11.83% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.94% | 0% | 0% | 0.09% |
| Dept financing | 4% | 0% | 0% | 50% |
| Current Ratio | 9.49% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 4.39% | 0% | 0% | 5.68% |
| Liquididy | 44% | 0% | 0% | 66% |